Eli Lilly and Co 2017 Integrated Report
The report highlights Lilly's 2017 business performance, including revenue of $22,871.3 million, an 8 percent increase, and 40,655 employees. It describes a clinical pipeline of 38 select new molecules and a commitment to reach 30 million people annually through Lilly 30x30 by 2030. Environmental performance data were based on 2016 verified data, with a 20% 2020 greenhouse-gas-intensity reduction goal against a 2012 baseline. Lilly reported 2017 CDP scores of B for climate change and A- for water.
Company: Eli Lilly and Co
Sector: Manufacturing
Country: United States
Year: 2017
Type: Integrated Report
Pages: 35
Eli Lilly and Co
The report highlights Lilly's 2017 business performance, including revenue of $22,871.3 million, an 8 percent increase, and 40,655 employees. It describes a clinical pipeline of 38 select new molecules and a commitment to reach 30 million people annually through Lilly 30x30 by 2030. Environmental performance data were based on 2016 verified data, with a 20% 2020 greenhouse-gas-intensity reduction goal against a 2012 baseline. Lilly reported 2017 CDP scores of B for climate change and A- for water.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees